Investor Relations

SIGA is concerned about the prevention and treatment of infectious diseases that affect people all over the world. We're very interested in your questions or comments.

SIGA has been a publicly traded company since 1997 (SIGA).

 

For Investor Relations questions or requests for literature, please contact


Lazar Partners
David Carey
Tel: 212-867-1768
dcarey@lazarpartners.com